[ Price : $8.95]
Bristol Myers Squibb reports that its COMMANDS Phase 3 study evaluating Reblozyl (luspatercept-aamt) met its primary endpoint in f...[ Price : $8.95]
FDA recommends that health care providers discuss alternative magnetic resonance imaging-guided breast biopsy options with patient...[ Price : $8.95]
FDA alerts patients and health care providers about a shortage of tracheostomy tubes, including Bivona tracheostomy tubes manufact...[ Price : $8.95]
FDA clears a Fresenius Medical 510(k) to implement changes to its 2008T hemodialysis machines that addresses an earlier FDA safety...[ Price : $8.95]
FDA issues Gilead a complete response letter on its BLA for bulevirtide, an investigational entry-inhibitor for treating adults wi...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Clostridioides difficile Infection: Developing Drugs for Tr...[ Price : $8.95]
Federal Register notice: FDA posts notifications that four information collections have been approved by OMB.[ Price : $8.95]
FDA relaxes advertising and promotion restrictions placed on six Covid-19 emergency use authorizations.